Results 221 to 230 of about 98,362 (265)

Evaluation of Free-Living Motor Symptoms in Patients With Parkinson Disease Through Smartwatches: Protocol for Defining Digital Biomarkers.

JMIR Res Protoc
Polvorinos-Fernández C, Sigcha L, Centeno-Cerrato M, de Arcas G, Grande M, Marín M, Pareés I, Martínez-Castrillo JC, Pavón I.   +8 more
europepmc   +1 more source

Insights From a Mixed Methods Analysis of 3 Health Technologies Used in Patients With Parkinson Disease: Mixed Methods Study.

J Med Internet Res
Pérez-Rangel D, Monje MHG, Grosjean S, Srp M, Antunes L, Bouça-Machado R, Cacho R, Domínguez Rodríguez S, Inocentes J, Lynch T, Tsakanika A, Fotiadis D, Rigas G, Růžička E, Ferreira JJ, Antonini A, Malpica N, Mestre T, Sánchez-Ferro Á, iCARE-PD Consortium.   +19 more
europepmc   +1 more source

Digital Biomarkers for Parkinson Disease: Bibliometric Analysis and a Scoping Review of Deep Learning for Freezing of Gait.

J Med Internet Res
Qi W, Shen S, Dong C, Zhao M, Zang S, Zhu X, Li J, Wang B, Shi Y, Dong Y, Shen H, Kang J, Lu X, Jiang G, Du J, Shu E, Zhou Q, Wang J, Cao S.   +18 more
europepmc   +1 more source

Correction to "The Prevalence of Parkinson Disease in Ukraine". [PDF]

Mov Disord Clin Pract
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Parkinson's disease

Neurologic Clinics, 2001
A number of changes have occurred in the management of Parkinson's disease in recent years, with the development of new therapeutic strategies based upon advances in pharmacotherapy and interventional procedures. The treatment of patients with Parkinson's disease is considered here with these advances in mind.
A E, Constantino, L S, Honig
openaire   +5 more sources

Parkinson's Disease and Parkinsonism

The American Journal of Medicine, 2019
Parkinson's disease is a progressive neurodegenerative disease characterized by tremor and bradykinesia and is a common neurologic ailment. Male sex and advancing age are independent risk factors and, as the population ages, is taking an increasing toll on productivity and medical resources.
openaire   +2 more sources

Genetics of Parkinson’s disease and parkinsonism

Expert Review of Neurotherapeutics, 2007
The past 10 years has seen a shift in our etiological concepts of Parkinson's disease, moving from a nearly exclusively environmentally mediated disease towards a complex disorder with important genetic contributors. The identification of responsible mutations in certain genes, particularly alpha-synuclein, Parkin, PINK1, DJ-1 and LRRK2, has increased ...
David J Nicholl, Michael R. Douglas, Alistair Lewthwaite   +2 more
openaire   +3 more sources

Parkinson's disease.

Clinical evidence, 2002
Around 1% of adults have Parkinson's disease, with a median time of 9 years between diagnosis and death.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of drug treatments in people with early-stage Parkinson's disease?
Carl E, Clarke, A Peter, Moore
openaire   +7 more sources

Genetics of Parkinson's disease and parkinsonism

Annals of Neurology, 2006
AbstractUntil 10 years ago, conventional wisdom held that Parkinson's disease was not a genetic disorder. Since that time, there have been a plethora of genetic findings, culminating in the cloning of several genes that derive from the loci given the nomenclature PARK1‐PARK12 (OMIM 168600).
Andrew B. Singleton, Huaiban Cai, John Hardy, Mark R. Cookson, Katrina Gwinn-Hardy   +4 more
openaire   +3 more sources

Identification of parkinsonism and Parkinson's disease

Drugs of Today, 2002
Parkinson's disease is a common movement disorder associated with considerable disability. The clinical syndrome of parkinsonism is based on the presence of core clinical features of rest tremor, bradykinesia, rigidity and impaired postural reflexes or gait.
openaire   +3 more sources